Lombard Odier Asset Management (Switzerland) Sa Glaukos Corp Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $308,257 - $368,672	7,025 Added 3.46%	209,938 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$40.82 - $57.75 $1.37 Million - $1.94 Million	33,658 Added 19.89%	202,913 $8.86 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $1.01 Million - $1.26 Million	21,513 Added 14.56%	169,255 $9.01 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $5.15 Million - $9.42 Million	147,742 New	147,742 $6.71 Million

Others Institutions Holding GKOS

# of Institutions

342

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

Black Rock Inc. New York, NY

8.04M
Shares

$1.26 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.87M
Shares

$919 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$342 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$306 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$257 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account